Efficacy, Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT01437397 · COMPLETED
Trial details
- NCT number
- NCT01437397
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2013-02-01
- Enrollment
- 1692
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.